Hepion Pharmaceuticals, Inc. (HEPA) stock
HEPAOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as CTRVP
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q/A on Nov 17, 2026Score 1/30
$0.10−0.00 (-1.45%)
Close on Oct 19, 2026Market cap $7.26MP/E –Yield –
Hepion Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Hepion Pharmaceuticals's enterprise value was $1.34M on Oct 19, 2026, against -$2.15M a year earlier. Over the last 5 years it ranged from -$38.06M to $15.44M, with a median of -$2.34M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $1.34M | – |
| 2025 | Dec 31, 2025 | -$1.62M | -191.5% |
| 2024 | Dec 31, 2024 | $1.77M | – |
| 2023 | Dec 29, 2023 | -$6.85M | – |
| 2022 | Dec 30, 2022 | -$36.28M | – |
| 2021 | Dec 31, 2021 | -$11.83M | -295.5% |
| 2020 | Dec 31, 2020 | $6.05M | +65.9% |
| 2019 | Dec 31, 2019 | $3.65M | – |
| 2018 | Dec 31, 2018 | -$10.32M | -172.5% |
| 2017 | Dec 29, 2017 | $14.23M | -77.6% |
| 2016 | Dec 30, 2016 | $63.50M | +94.2% |
| 2015 | Dec 31, 2015 | $32.70M | -33.2% |
| 2014 | Dec 31, 2014 | $48.99M | – |
See a number that looks wrong?